S5E7 - Back to basics: the Prothrombin Time assay

Welcome to Ask Stago, The Podcast dedicated to provide expert answers to your expert questions in coagulation.

In this “back to basics” mini-series, Dr LaShanta Brice will discuss the clinical utility of the three most common parameters tested in the lab, the PT, APTT and Fibrinogen.

Today we are going to cover the Prothrombin Time!

We will discover why an order for a PT would be received by the lab, generally why the PT is used in practice and some emerging trends particularly when considering the INR clinic.

Happy listening!

Literature source: CLSI H47 One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test

 

 

Content is scientific and technical in nature. It is intended as an educational tool for laboratory professionals and topics discussed are not intended as recommendations or as commentary on appropriate clinical practice.

Tweet Share

Email

Previous episode

S5E6 - Improving your lab productivity with the STA Workcell Max

Presented by Lisa Gannon & Anne-Cécile Ortega // Special guest, Emily Pullen Product line manager at Stago North America

Next episode

S5E8 - Anti Xa and UFH monitoring

Presented by Lisa Gannon & Anne-Cécile Ortega // Special guest: Dr. Isabelle Gouin-Thibault, Medical Pathologist and the Head of the Hemostasis Department at the University Hospital of Rennes (France)

About Ask Stago (english version)

A podcast by Stago

Check out all the episodes of Ask Stago (english version)

Episode comments

Subscribers 1

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

What do you think about this episode? Leave a comment!

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

• Insert image from URL

×

• Desktop
• Tablet
• Phone

• Add your comment